Agenus shared a post on LinkedIn:
“Hear from Agenus CEO Garo Armen on our recent partnership with Zydus Group – an aligned collaborator positioned to help expand our clinical trial efforts in India and accelerate data generation for our immunotherapy programs. This collaboration underscores India as a key partner to the U.S. in advancing global access to BOT and BAL.”
Read Full Press Release.
Proceed to the video attached to the post.
Read Further.
